BRIEF-China's Zhongyuan Union Stem Cell to acquire ZhiCheng Biological via share issue, cash

Mon Feb 24, 2014 12:30am EST

Related Topics

Feb 24 (Reuters) - Zhongyuan Union Stem Cell Bio-Engineering Corp

* Says plans to acquire Shanghai ZhiCheng Biological Technology Co Ltd via share issue and cash payment

* Says plans to issue up to 33.71 million shares at 24.5 yuan ($4.02) per share

* Says plans to issue shares to its controlling shareholder by raising 266 mln yuan for acquisition's cash payment

Source text in Chinese :

Further company coverage: ($1 = 6.0914 Chinese yuan) (Reporting by Hong Kong and Shanghai newsrooms)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.